Enfermedades Sistémicas de Base Autoinmune

Nieto-Gonzalez, JC; Trives-Folguera, L; Melgarejo-Ortuno, A; Ais, A; Serrano-Benavente, B; Sanjurjo, M; Alvaro-Gracia, JM; Saez, IM.

Persistence and adherence to biologic therapies in juvenile idiopathic arthritis

Scientific Reports. 2021; 11(1): 16195-16195 Nº de citas: 4 [doi:10.1038/s41598-021-95252-8]

Vallejo, MA; Vallejo-Slocker, L; Offenbaecher, M; Hirsch, JK; Toussaint, LL; Kohls, N; Sirois, F; Rivera, J.

Psychological Flexibility Is Key for Reducing the Severity and Impact of Fibromyalgia

International Journal of Environmental Research and Public Health. 2021; 18(14): Nº de citas: 9 [doi:10.3390/ijerph18147300]

Basiaga, ML; Stern, SM; Mehta, JJ; Edens, C; Randell, RL; Pomorska, A; Irga-Jaworska, N; Ibarra, MF; Bracaglia, C; Nicolai, R; Susic, G; Boneparth, A; Srinivasalu, H; Dizon, B; Kamdar, AA; Goldberg, B; Knupp-Oliveira, S; Anton, J; Mosquera, JM; Appenzeller, S; O'Neil, KM; Protopapas, SA; Saad-Magalhaes, C; Akikusa, JD; Thatayatikom, A; Cha, S; Nieto-Gonzalez, JC; Lo, MS; Treemarcki, EB; Yokogawa, N; Lieberman, SM; Childhood Arthrit Rheumatology Res; Int Childhood Sjogren Syndrome Wor.

Childhood Sjogren syndrome: features of an international cohort and application of the 2016 ACR/EULAR classification criteria

RHEUMATOLOGY. 2021; 60(7): 3144-3155 Nº de citas: 57 [doi:10.1093/rheumatology/keaa757]

Saadoun, D; Vieira, M; Vautier, M; Baraliakos, X; Andreica, I; da Silva, JAP; Sousa, M; Luis, M; Khmelinskii, N; Gracia, JMA; Castrejon, I; Gonzalez, JCN; Scire, CA; Silvagni, E; Bortoluzzi, A; Penn, H; Hamdulay, S; Machado, PM; Fautrel, B; Cacoub, P; Resche-Rigon, M; Gossec, L.

SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study

Lancet Rheumatology. 2021; 3(7): 481-488 Nº de citas: 34 [doi:10.1016/S2665-9913(21)00112-0]

Collada, JM; Martinez-Barrio, J; Serrano-Benavente, B; Castrejon, I; Nieto-Gonzalez, JC; Motta, LRC; Folguera, LT; Alvaro-Gracia, JM.

Subclavian artery involvement in patients with giant cell arteritis: do we need a modified Halo Score?

CLINICAL RHEUMATOLOGY. 2021; 40(7): 2821-2827 Nº de citas: 8 [doi:10.1007/s10067-020-05577-4]

Farinas, MC; Gonzalez-Rico, C; Fernandez-Martinez, M; Fortun, J; Escudero-Sanchez, R; Moreno, A; Bodro, M; Munoz, P; Valerio, M; Montejo, M; Nieto, J; Millan, JCRS; Casafont-Morencos, F; Martinez-Martinez, L; Farinas-Alvarez, C.

Oral decontamination with colistin plus neomycin in solid organ transplant recipients colonized by multidrug-resistant Enterobacterales: a multicentre, randomized, controlled, open-label, parallel-group clinical trial

CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(6): 856-863 Nº de citas: 25 [doi:10.1016/j.cmi.2020.12.016]

Rodriguez-Garcia, SC; Montes, N; Ivorra-Cortes, J; Triguero-Martinez, A; Rodriguez-Rodriguez, L; Castrejon, I; Carmona, L; Gonzalez-Alvaro, I.

Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression

Frontiers In Medicine. 2021; 8: 669688-669688 Nº de citas: 3 [doi:10.3389/fmed.2021.669688]

Rivera J; Castrejón I; Vallejo-Slocker L; Offenbächer M; Molina-Collada J; Trives L; López K; Caballero L; Hirsch JK; Toussaint L; Nieto JC; Alvaro-Gracia JM; Vallejo MA.

Clinical impact of confinement due to the COVID-19 pandemic on patients with fibromyalgia: a cohort study.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021; 39 Suppl 130(3): 78-81

Remuzgo-Martinez, S; Atienza-Mateo, B; Ocejo-Vinyals, JG; Pulito-Cueto, V; Prieto-Pena, D; Genre, F; Marquez, A; Llorca, J; Cuesta, VMM; Fernandez, DI; Riesco, L; Ortego-Centeno, N; Gomez, NP; Mera, A; Martinez-Barrio, J; Lopez-Longo, FJ; Lera-Gomez, L; Moriano, C; Diez, E; Tomero, E; Calvo-Alen, J; Romero-Bueno, F; Sanchez-Pernaute, O; Nuno, L; Bonilla, G; Grafia, I; Prieto-Gonzalez, S; Narvaez, J; Trallero-Araguas, E; Selva-O'Callaghan, A; Gualillo, O; Martin, J; Cavagna, L; Castaneda, S; Cifrian, JM; Renzoni, EA; Lopez-Mejias, R; Gonzalez-Gay, MA.

HLA association with the susceptibility to anti-synthetase syndrome

JOINT BONE SPINE. 2021; 88(3): 105115-105115 Nº de citas: 10 [doi:10.1016/j.jbspin.2020.105115]

Riancho-Zarrabeitia, L; Martinez-Taboada, V; Rua-Figueroa, I; Alonso, F; Galindo-Izquierdo, M; Ovalles, J; Olive-Marques, A; Vazquez, NM; Calvo-Alen, J; Menor-Almagro, R; Tomero-Muriel, E; Uriarte-Isacelaya, E; Botenau, A; Andres, M; Freire-Gonzalez, M; Soler, GS; Ruiz-Lucea, E; Ibanez-Barcelo, M; Castellvi, I; Galisteo, C; Vila, VQ; Raya, E; Narvaez, J; Exposito, L; Hernandez-Beriain, JA; Horcada, L; Aurrecoechea, E; Pego-Reigosa, JM.

Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021; 39(3): 555-563 Nº de citas: 2

Cid, LAT; Soleto, KCY; Montoro-Alvarez, M; Tenorio, CS; Silva-Riveiro, A; Lopez-Ceron, A; Alfaro, AMA; Motta, LRC; Benavente, BS; Martinez-Barrio, J; Ovalles-Bonilla, JG; Fernandez, CMG; Saez, IM; Nieto-Gonzalez, JC.

Clinical impact of nailfold capillaroscopy in daily clinical practice

Reumatologia Clinica. 2021; 17(5): 258-262 Nº de citas: 2 [doi:10.1016/j.reuma.2019.07.008]

Collada, JM; Macia-Villa, C; Plasencia, C; Alvaro-Gracia, JM; de Miguel, E.

Doppler enthesitis: a potential useful outcome in the assessment of axial spondyloarthritis and psoriatic arthritis

CLINICAL RHEUMATOLOGY. 2021; 40(5): 2013-2020 Nº de citas: 11 [doi:10.1007/s10067-020-05450-4]

Alegre-Sancho, JJ; Juanola, X; Rodriguez-Heredia, JM; Manero, J; Villa-Blanco, I; Laiz, A; Arteaga, MJ; Cea-Calvo, L; Gonzalez, CM.

Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis A retrospective study

MEDICINE. 2021; 100(13): Nº de citas: 8 [doi:10.1097/MD.0000000000025223]

Frutos, AR; Holgado, S; Berge, AS; Casas, I; Olive, A; Lopez-Longo, FJ; Calvo-Alen, J; Galindo, M; Fernandez-Nebro, A; Pego-Reigosa, JM; Rua-Figueroa, I; RELESSER Grp.

Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER)

RHEUMATOLOGY. 2021; 60(4): 1793-1803 Nº de citas: 34 [doi:10.1093/rheumatology/keaa477]

Nieto, JC; Arajol, C; Carmona, L; Marras, C; Cea-Calvo, L.

Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: a systematic review

IMMUNOTHERAPY. 2021; 13(5): 433-458 Nº de citas: 5 [doi:10.2217/imt-2021-0011]

Alvaro-Gracia, JM; Garcia-Llorente, JF; Valderrama, M; Gomez, S; Montoro, M.

Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review

Rheumatology and Therapy. 2021; 8(1): 17-40 Nº de citas: 27 [doi:10.1007/s40744-020-00258-9]

Collada, JM; Castrejon, I; Perez, M; Nieto-Gonzalez, JC; Gonzalez, T; Rivera, J; Gonzalez, C; Alvaro-Gracia, JM.

Clinical impact of musculoskeletal ultrasound on rheumatoid arthritis in routine care

International Journal of Rheumatic Diseases. 2021; 24(3): 341-346 Nº de citas: 4 [doi:10.1111/1756-185X.14040]

Masmitja, JG; Fernandez, CMG; Castro, SG; Laserna, FJR.

Efficacy of Tofacitinib in the Treatment of Psoriatic Arthritis: A Systematic Review

ADVANCES IN THERAPY. 2021; 38(2): 868-884 Nº de citas: 10 [doi:10.1007/s12325-020-01585-7]